Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of everolimus in digestive cancer
2012-002224-32Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of everolimus in gastrointestinal cancer, sponsored by Fédération Francophone de Cancérologie Digestive. Started Sep 2012; status: completed.
02
Drugs
everolimus
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on 2012-002224-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002224-32.